These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24231201)

  • 21. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials.
    Cortese S; Ferrin M; Brandeis D; Buitelaar J; Daley D; Dittmann RW; Holtmann M; Santosh P; Stevenson J; Stringaris A; Zuddas A; Sonuga-Barke EJ;
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):164-74. PubMed ID: 25721181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.
    Kempton S; Vance A; Maruff P; Luk E; Costin J; Pantelis C
    Psychol Med; 1999 May; 29(3):527-38. PubMed ID: 10405075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hot executive control and response to a stimulant in a double-blind randomized trial in children with ADHD.
    Yarmolovsky J; Szwarc T; Schwartz M; Tirosh E; Geva R
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):73-82. PubMed ID: 26966012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder.
    Blum NJ; Jawad AF; Clarke AT; Power TJ
    Dev Med Child Neurol; 2011 Sep; 53(9):843-849. PubMed ID: 21585365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.
    Langleben DD; Monterosso J; Elman I; Ash B; Krikorian G; Austin G
    Psychiatry Res; 2006 Mar; 141(3):315-20. PubMed ID: 16516306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive effects of methylphenidate in adults with attention-deficit/hyperactivity disorder: A meta-analysis.
    Pievsky MA; McGrath RE
    Neurosci Biobehav Rev; 2018 Jul; 90():447-455. PubMed ID: 29751051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dual tasking and methylphenidate on gait in children with attention deficit hyperactivity disorder.
    Möhring W; Klupp S; Grob A
    Hum Mov Sci; 2018 Dec; 62():48-57. PubMed ID: 30243117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings.
    Silk TJ; Newman DP; Eramudugolla R; Vance A; Bellgrove MA
    Neuropsychologia; 2014 Apr; 56():178-83. PubMed ID: 24486422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of methylphenidate on intelligence and attention components in boys with attention-deficit/hyperactivity disorder.
    Hellwig-Brida S; Daseking M; Keller F; Petermann F; Goldbeck L
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):245-53. PubMed ID: 21663427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P; Kodesh A; Weizman A
    Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
    Hegvik TA; Jacobsen KK; Fredriksen M; Zayats T; Haavik J
    J Neural Transm (Vienna); 2016 Aug; 123(8):859-65. PubMed ID: 27091191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Rubia K; Alegria AA; Cubillo AI; Smith AB; Brammer MJ; Radua J
    Biol Psychiatry; 2014 Oct; 76(8):616-28. PubMed ID: 24314347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.
    Moukhtarian TR; Cooper RE; Vassos E; Moran P; Asherson P
    Eur Psychiatry; 2017 Jul; 44():198-207. PubMed ID: 28646732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.